Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
If a company builds assets at 21.2% a year, faster than its revenue growth rate of 13.3% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Shenzhen Lifotronic Technology Co's average Total Assets Growth Rate was 5.90% per year.
During the past 3 years, the average Total Assets Growth Rate was 11.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 21.20% per year.
During the past 10 years, Shenzhen Lifotronic Technology Co's highest 3-Year average Total Assets Growth Rate was 60.40%. The lowest was 11.60%. And the median was 31.10%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Shenzhen Lifotronic Technology Co's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Shenzhen Lifotronic Technology Co Total Assets Related Terms
Shenzhen Lifotronic Technology Co Total Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Lifotronic Technology Co Total Assets Chart
Shenzhen Lifotronic Technology Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Lifotronic Technology Co (SHSE:688389) has a Total Assets of ¥2,526 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Shenzhen Lifotronic Technology Co and its competitors.
Is Shenzhen Lifotronic Technology Co's Total Assets too high?
Shenzhen Lifotronic Technology Co's current Total Assets is ¥2,526 Mil. Overall, Shenzhen Lifotronic Technology Co has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Lifotronic Technology Co's Total Assets compare to ABT and SYK?
Shenzhen Lifotronic Technology Co's Total Assets of ¥2,526 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Shenzhen Lifotronic Technology Co and its competitors. Shenzhen Lifotronic Technology Co's current Total Assets is ¥2,526 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Lifotronic Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co (SHSE:688389) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.72, compared to a current price of ¥10.49 — trading 33.3% below its estimated fair value. The current Total Assets is ¥2,526 Mil. Shenzhen Lifotronic Technology Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Shenzhen Lifotronic Technology Co (SHSE:688389), the current Total Assets is ¥2,526 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Lifotronic Technology Co (SHSE:688389) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co stock appears to be undervalued.
The current stock price of ¥10.49 is trading 33.3% below its estimated GF Value™ of ¥15.72.
GuruFocus considers Shenzhen Lifotronic Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688389:
Total Assets: ¥2,526 Mil
GF Value™: ¥15.72 vs. price of ¥10.49 (33.3% below fair value)
No single metric tells the full story. See the SHSE:688389 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Lifotronic Technology Co Business Description
Shenzhen Lifotronic Technology Co Ltd is a China based company engaged in the development, production and sales of therapeutic and rehabilitation products, in vitro diagnostic equipment and supporting reagents.
89GF Score
Get the complete analysis for SHSE:688389
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688389 has been successfully added to your 
